1. Home
  2. TLSA vs INVE Comparison

TLSA vs INVE Comparison

Compare TLSA & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • INVE
  • Stock Information
  • Founded
  • TLSA 2013
  • INVE 1990
  • Country
  • TLSA United Kingdom
  • INVE United States
  • Employees
  • TLSA N/A
  • INVE 394
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • INVE Computer peripheral equipment
  • Sector
  • TLSA Health Care
  • INVE Technology
  • Exchange
  • TLSA Nasdaq
  • INVE Nasdaq
  • Market Cap
  • TLSA 87.8M
  • INVE 82.2M
  • IPO Year
  • TLSA 2000
  • INVE 1997
  • Fundamental
  • Price
  • TLSA $0.82
  • INVE $3.44
  • Analyst Decision
  • TLSA
  • INVE Strong Buy
  • Analyst Count
  • TLSA 0
  • INVE 2
  • Target Price
  • TLSA N/A
  • INVE $7.25
  • AVG Volume (30 Days)
  • TLSA 392.4K
  • INVE 31.3K
  • Earning Date
  • TLSA 03-04-2025
  • INVE 03-05-2025
  • Dividend Yield
  • TLSA N/A
  • INVE N/A
  • EPS Growth
  • TLSA N/A
  • INVE N/A
  • EPS
  • TLSA N/A
  • INVE 3.10
  • Revenue
  • TLSA N/A
  • INVE $104,217,000.00
  • Revenue This Year
  • TLSA N/A
  • INVE N/A
  • Revenue Next Year
  • TLSA N/A
  • INVE N/A
  • P/E Ratio
  • TLSA N/A
  • INVE $1.11
  • Revenue Growth
  • TLSA N/A
  • INVE 70.57
  • 52 Week Low
  • TLSA $0.41
  • INVE $2.95
  • 52 Week High
  • TLSA $1.74
  • INVE $9.24
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 54.65
  • INVE 40.36
  • Support Level
  • TLSA $0.65
  • INVE $3.41
  • Resistance Level
  • TLSA $0.94
  • INVE $3.67
  • Average True Range (ATR)
  • TLSA 0.06
  • INVE 0.19
  • MACD
  • TLSA 0.02
  • INVE 0.01
  • Stochastic Oscillator
  • TLSA 61.26
  • INVE 12.20

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

Share on Social Networks: